Introducing molecular testing of pyrazinamide susceptibility improves multidrug-resistant tuberculosis treatment outcomes: a prospective cohort study.
Sun F, Li Y, Chen Y, Guan W, Jiang X, Wang X, Ren P, Li J, Shi J, He G, Wu M, Tang P, Wang F, Sheng Y, Huang F, Zhou Z, Huang H, Hong L, Liu Q, Zhang Y, Zhang W.
Sun F, et al. Among authors: tang p.
Eur Respir J. 2019 Mar 14;53(3):1801770. doi: 10.1183/13993003.01770-2018. Print 2019 Mar.
Eur Respir J. 2019.
PMID: 30578402
Free article.
Clinical Trial.